Hollingworth, William http://orcid.org/0000-0002-0840-6254
Fawsitt, Christopher G.
Dixon, Padraig
Duffy, Larisa
Araya, Ricardo
Peters, Tim J.
Thom, Howard
Welton, Nicky J.
Wiles, Nicola
Lewis, Glyn
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
https://doi.org/10.1007/s41669-019-00188-5
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT (Results)
https://doi.org/10.3310/pgfar07100
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-0610-10048)
Article History
First Online: 27 November 2019
Compliance with Ethical Standards
:
: The study was funded by the UK National Institute for Health Research (NIHR). The PANDA trial is independent research commissioned by the NIHR Programme Grant for Applied Research (RP-PG-0610-10048). The views expressed in this publication are those of the author(s) and not necessarily those of the sponsor, NHS, NIHR or Department of Health. The funder had no role in the study design, data collection, data analysis, interpretation of data or writing of the report. PD acknowledges support from a Medical Research Council Skills Development Fellowship (MR/P014259/1). PD is a member of the MRC Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council and the University of Bristol (MC_UU_12013/1, MC_UU_12013/9). HT was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol and by the Medical Research Council Hubs for Trials Methodology Research Collaboration and innovation in Difficult and Complex randomised controlled Trials In Invasive procedures (ConDuCT-II) hub.
: GL reports grant income and income from being an expert witness. NJW reports a grant from Pfizer Ltd which part-funded a researcher on a methodology project using historical data in clinical areas unrelated to this work. HT reports personal fees for consultancy work from Pfizer, Novartis Pharma, Hoffman La-Roche, and Eli Lilly and Company, all outside this work. WH, CF, PD, LD, RA TP and NW report no conflict of interest other than the NIHR funding described above.
: The PANDA RCT was approved by NRES Committee East of England—Cambridge South, ref 13/EE/0418. All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.